Trials / Completed
CompletedNCT00249457
Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2
A Therapeutic Workplace for Drug Abusers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether long-term exposure to the Therapeutic Workplace intervention could sustain drug abstinence over an extended period of time in heroin- and cocaine-dependent, unemployed, treatment-resistant young mothers.
Detailed description
The current study is a continuation of the research into the development and evaluation of a novel treatment designed to address the chronic, persistent nature of drug addiction. This treatment, called the Therapeutic Workplace, integrates abstinence reinforcement contingencies of proven efficacy into a model supported work program. Participants were paid to work or to train in the Therapeutic Workplace but had to provide drug-free urine samples to gain daily access. Forty participants were randomly assigned to a Therapeutic Workplace or usual care control group. Therapeutic Workplace participants could work for about 5 years. This study reports the effects of the intervention over a follow-up period of 8 years after treatment initiation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Contingency management | Invited to attend the Therapeutic Workplace 3 hr per day, Monday through Friday. Each day when a participant reported to the workplace, she was required to provide a urine sample. If the sample tested negative for opiates and cocaine, she was allowed to work that day. Participants who gained entrance to the workplace participated in basic skills education and job skills training throughout each 3-hr work shift. |
Timeline
- Start date
- 1996-10-01
- Primary completion
- 2006-01-01
- Completion
- 2006-01-01
- First posted
- 2005-11-07
- Last updated
- 2017-10-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00249457. Inclusion in this directory is not an endorsement.